Treatment and diagnostics sarcoidosis in Tokyo, Japan

Treatment of sarcoidosis in Tokyo is a competent systemic strategy that helps reduce inflammation, relieve exacerbations and relapses, and eliminate associated disorders. Sarcoidosis is a chronic inflammation concentrated mainly in lung and lymphatic tissue. The disease is also called “benign lymphogranulomatosis.” Despite the seemingly moderate nature of the condition, it can lead to critical consequences up to acute respiratory failure.

Diagnosis of sarcoidosis in Tokyo is carried out by the following methods:

• laboratory tests of blood and sputum,
• digital radiography,
• CT and MRI of the chest organs,
• PET-CT if cancer is suspected,
• spirometry,
• bronchoscopy with transthoracic biopsy,
• pleural puncture.

After establishing the exact diagnosis and differentiating the nature of the disease, the doctor prescribes treatment. The standard of sarcoidosis therapy is glucocorticosteroid anti-inflammatory drugs.

In addition to pharmacotherapy, the following methods are used:

• individually developed molecular targeted therapy,
• biological treatment,
• cytostatic drugs,
• administration of antimetabolites,
• use of immunosuppressants.

Traditional conservative therapy is supplemented by physiotherapy and spa procedures. Patients with a severe course are recommended special rehabilitation programs.